Show simple item record

dc.contributor.authorZhao, Y
dc.contributor.authorGardner, EJ
dc.contributor.authorTuke, MA
dc.contributor.authorZhang, H
dc.contributor.authorPietzner, M
dc.contributor.authorKoprulu, M
dc.contributor.authorJia, RY
dc.contributor.authorRuth, KS
dc.contributor.authorWood, AR
dc.contributor.authorBeaumont, RN
dc.contributor.authorTyrrell, J
dc.contributor.authorJones, SE
dc.contributor.authorLango Allen, H
dc.contributor.authorDay, FR
dc.contributor.authorLangenberg, C
dc.contributor.authorFrayling, TM
dc.contributor.authorWeedon, MN
dc.contributor.authorPerry, JRB
dc.contributor.authorOng, KK
dc.contributor.authorMurray, A
dc.date.accessioned2022-07-04T08:16:39Z
dc.date.issued2022-06-09
dc.date.updated2022-07-03T12:10:39Z
dc.description.abstractPURPOSE: The study aimed to systematically ascertain male sex chromosome abnormalities, 47,XXY (Klinefelter syndrome [KS]) and 47,XYY, and characterize their risks of adverse health outcomes. METHODS: We analyzed genotyping array or exome sequence data in 207,067 men of European ancestry aged 40 to 70 years from the UK Biobank and related these to extensive routine health record data. RESULTS: Only 49 of 213 (23%) of men whom we identified with KS and only 1 of 143 (0.7%) with 47,XYY had a diagnosis of abnormal karyotype on their medical records or self-report. We observed expected associations for KS with reproductive dysfunction (late puberty: risk ratio [RR] = 2.7; childlessness: RR = 4.2; testosterone concentration: RR = -3.8 nmol/L, all P < 2 × 10-8), whereas XYY men appeared to have normal reproductive function. Despite this difference, we identified several higher disease risks shared across both KS and 47,XYY, including type 2 diabetes (RR = 3.0 and 2.6, respectively), venous thrombosis (RR = 6.4 and 7.4, respectively), pulmonary embolism (RR = 3.3 and 3.7, respectively), and chronic obstructive pulmonary disease (RR = 4.4 and 4.6, respectively) (all P < 7 × 10-6). CONCLUSION: KS and 47,XYY were mostly unrecognized but conferred substantially higher risks for metabolic, vascular, and respiratory diseases, which were only partially explained by higher levels of body mass index, deprivation, and smoking.en_GB
dc.description.sponsorshipMedical Research Council (MRC)en_GB
dc.description.sponsorshipGates Fellowshipen_GB
dc.description.sponsorshipAcademy of Medical Sciencesen_GB
dc.description.sponsorshipWellcome Trusten_GB
dc.description.sponsorshipUK Department of Business, Energy and Industrial Strategyen_GB
dc.description.sponsorshipBritish Heart Foundationen_GB
dc.description.sponsorshipDiabetes UKen_GB
dc.description.sponsorshipCancer Research UKen_GB
dc.format.extentS1098-3600(22)00777-8-
dc.format.mediumPrint-Electronic
dc.identifier.citationPublished online 9 June 2022en_GB
dc.identifier.doihttps://doi.org/10.1016/j.gim.2022.05.011
dc.identifier.grantnumberMR/T00200X/1en_GB
dc.identifier.grantnumberMC_UU_00006/1en_GB
dc.identifier.grantnumberMC_UU_00006/2en_GB
dc.identifier.grantnumberSBF004∖1079en_GB
dc.identifier.grantnumberSBF006∖1134en_GB
dc.identifier.grantnumberC18281/A29019en_GB
dc.identifier.urihttp://hdl.handle.net/10871/130141
dc.identifierORCID: 0000-0002-6174-6135 (Weedon, Michael N)
dc.language.isoenen_GB
dc.publisherElsevier / American College of Medical Genetics and Genomicsen_GB
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/35687092en_GB
dc.relation.urlhttps://www.ukbiobank.ac.uk/enable-your-research/apply-for-accessen_GB
dc.rights© Crown Copyright 2022. Published by Elsevier Inc. on behalf of American College of Medical Genetics and Genomics. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).en_GB
dc.subject47,XYYen_GB
dc.subjectDisorders of sexual developmenten_GB
dc.subjectEndocrinologyen_GB
dc.subjectKlinefelter syndromeen_GB
dc.subjectThrombosisen_GB
dc.subjectType 2 diabetesen_GB
dc.titleDetection and characterization of male sex chromosome abnormalities in the UK Biobank studyen_GB
dc.typeArticleen_GB
dc.date.available2022-07-04T08:16:39Z
dc.identifier.issn1098-3600
exeter.place-of-publicationUnited States
dc.descriptionThis is the final version. Available on open access from Elsevier via the DOI in this reocrden_GB
dc.descriptionData Availability: All data are available via the UK Biobank Access Management System https://www.ukbiobank.ac.uk/enable-your-research/apply-for-access.en_GB
dc.identifier.eissn1530-0366
dc.identifier.journalGenetics in Medicineen_GB
dc.relation.ispartofGenet Med
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/en_GB
dcterms.dateAccepted2022-05-16
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2022-06-09
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2022-07-04T08:13:01Z
refterms.versionFCDVoR
refterms.dateFOA2022-07-04T08:16:46Z
refterms.panelAen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record

© Crown Copyright 2022. Published by Elsevier Inc. on behalf of American College of Medical Genetics and Genomics. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Except where otherwise noted, this item's licence is described as © Crown Copyright 2022. Published by Elsevier Inc. on behalf of American College of Medical Genetics and Genomics. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).